
At the Federal Scientific and Clinical Center of Medical Radiology and Oncology of Russia in Dimitrovgrad, the first patients underwent successful radionuclide therapy using a radiopharmaceutical drug based on lutetium-177. The drug was developed with the participation of specialists from the Research Institute of Nuclear Reactors, a long-time partner of …